Literature DB >> 10611356

Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy.

N M Ferguson1, F deWolf, A C Ghani, C Fraser, C A Donnelly, P Reiss, J M Lange, S A Danner, G P Garnett, J Goudsmit, R M Anderson.   

Abstract

Antigen-induced stimulation of the immune system can generate heterogeneity in CD4+ T cell division rates capable of explaining the temporal patterns seen in the decay of HIV-1 plasma RNA levels during highly active antiretroviral therapy. Posttreatment increases in peripheral CD4+ T cell counts are consistent with a mathematical model in which host cell redistribution between lymph nodes and peripheral blood is a function of viral burden. Model fits to patient data suggest that, although therapy reduces HIV replication below replacement levels, substantial residual replication continues. This residual replication has important consequences for long-term therapy and the evolution of drug resistance and represents a challenge for future treatment strategies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10611356      PMCID: PMC24791          DOI: 10.1073/pnas.96.26.15167

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection.

Authors:  W Cavert; D W Notermans; K Staskus; S W Wietgrefe; M Zupancic; K Gebhard; K Henry; Z Q Zhang; R Mills; H McDade; C M Schuwirth; J Goudsmit; S A Danner; A T Haase
Journal:  Science       Date:  1997-05-09       Impact factor: 47.728

2.  Quantitative image analysis of HIV-1 infection in lymphoid tissue.

Authors:  A T Haase; K Henry; M Zupancic; G Sedgewick; R A Faust; H Melroe; W Cavert; K Gebhard; K Staskus; Z Q Zhang; P J Dailey; H H Balfour; A Erice; A S Perelson
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

3.  HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.

Authors:  A S Perelson; A U Neumann; M Markowitz; J M Leonard; D D Ho
Journal:  Science       Date:  1996-03-15       Impact factor: 47.728

4.  Human immunodeficiency virus drug therapy and virus load.

Authors:  S Bonhoeffer; J M Coffin; M A Nowak
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.

Authors:  M R Furtado; D S Callaway; J P Phair; K J Kunstman; J L Stanton; C A Macken; A S Perelson; S M Wolinsky
Journal:  N Engl J Med       Date:  1999-05-27       Impact factor: 91.245

6.  Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation.

Authors:  D Goletti; D Weissman; R W Jackson; N M Graham; D Vlahov; R S Klein; S S Munsiff; L Ortona; R Cauda; A S Fauci
Journal:  J Immunol       Date:  1996-08-01       Impact factor: 5.422

7.  Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma.

Authors:  R Schuurman; D Descamps; G J Weverling; S Kaye; J Tijnagel; I Williams; R van Leeuwen; R Tedder; C A Boucher; F Brun-Vezinet; C Loveday
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

8.  Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine.

Authors:  B Brichacek; S Swindells; E N Janoff; S Pirruccello; M Stevenson
Journal:  J Infect Dis       Date:  1996-12       Impact factor: 5.226

9.  Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.

Authors:  S K Stanley; M A Ostrowski; J S Justement; K Gantt; S Hedayati; M Mannix; K Roche; D J Schwartzentruber; C H Fox; A S Fauci
Journal:  N Engl J Med       Date:  1996-05-09       Impact factor: 91.245

10.  Activation of virus replication after vaccination of HIV-1-infected individuals.

Authors:  S I Staprans; B L Hamilton; S E Follansbee; T Elbeik; P Barbosa; R M Grant; M B Feinberg
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more
  15 in total

1.  Decelerating decay of latently infected cells during prolonged therapy for human immunodeficiency virus type 1 infection.

Authors:  Viktor Müller; Javier Flavio Vigueras-Gómez; Sebastian Bonhoeffer
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

2.  Modelling the human immune system by combining bioinformatics and systems biology approaches.

Authors:  Nicolas Rapin; Can Kesmir; Sune Frankild; Morten Nielsen; Claus Lundegaard; Søren Brunak; Ole Lund
Journal:  J Biol Phys       Date:  2006-10-27       Impact factor: 1.365

3.  Quantification of intrinsic residual viral replication in treated HIV-infected patients.

Authors:  C Fraser; N M Ferguson; R M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

4.  Release of virus from lymphoid tissue affects human immunodeficiency virus type 1 and hepatitis C virus kinetics in the blood.

Authors:  V Müller; A F Marée; R J De Boer
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Role of avidity and breadth of the CD4 T cell response in progression to AIDS.

Authors:  Hester Korthals Altes; Rob de Boer; Maarten Boerlijst
Journal:  Proc Biol Sci       Date:  2006-07-07       Impact factor: 5.349

6.  Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection.

Authors:  Marc K Hellerstein; Rebecca A Hoh; Mary Beth Hanley; Denise Cesar; Daniel Lee; Richard A Neese; Joseph M McCune
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 7.  The role of antigenic stimulation and cytotoxic T cell activity in regulating the long-term immunopathogenesis of HIV: mechanisms and clinical implications.

Authors:  C Fraser; N M Ferguson; F de Wolf; R M Anderson
Journal:  Proc Biol Sci       Date:  2001-10-22       Impact factor: 5.349

8.  Transient viremia, plasma viral load, and reservoir replenishment in HIV-infected patients on antiretroviral therapy.

Authors:  Laura E Jones; Alan S Perelson
Journal:  J Acquir Immune Defic Syndr       Date:  2007-08-15       Impact factor: 3.731

Review 9.  Modeling HIV persistence, the latent reservoir, and viral blips.

Authors:  Libin Rong; Alan S Perelson
Journal:  J Theor Biol       Date:  2009-06-17       Impact factor: 2.691

10.  Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.

Authors:  Libin Rong; Alan S Perelson
Journal:  PLoS Comput Biol       Date:  2009-10-16       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.